These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 27402133)
1. Immune response in human chromoblastomycosis and eumycetoma - focusing on human interleukin-17A, interferon-gamma, tumour necrosis factor-alpha, interleukin-1 beta and human beta-defensin-2. Leeyaphan C; Hau C; Takeoka S; Tada Y; Bunyaratavej S; Pattanaprichakul P; Sitthinamsuwan P; Chaiprasert A; Sasajima Y; Makimura K; Watanabe S Mycoses; 2016 Dec; 59(12):751-756. PubMed ID: 27402133 [TBL] [Abstract][Full Text] [Related]
2. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464 [TBL] [Abstract][Full Text] [Related]
3. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells. Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activity of IL-37 in asthmatic children: Correlation with inflammatory cytokines TNF-α, IL-β, IL-6 and IL-17A. Charrad R; Berraïes A; Hamdi B; Ammar J; Hamzaoui K; Hamzaoui A Immunobiology; 2016 Feb; 221(2):182-7. PubMed ID: 26454413 [TBL] [Abstract][Full Text] [Related]
5. Arthritis is inhibited in Borrelia-primed and infected interleukin-17A-deficient mice after administration of anti-gamma-interferon, anti-tumor necrosis factor alpha and anti-interleukin-6 antibodies. Kuo J; Warner TF; Schell RF Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859307 [TBL] [Abstract][Full Text] [Related]
6. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Joly S; Organ CC; Johnson GK; McCray PB; Guthmiller JM Mol Immunol; 2005 May; 42(9):1073-84. PubMed ID: 15829297 [TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173 [TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokine responses in patients with psoriasis. Kouris A; Pistiki A; Katoulis A; Georgitsi M; Giatrakou S; Papadavid E; Netea MG; Stavrianeas N; Giamarellos-Bourboulis EJ Eur Cytokine Netw; 2014; 25(4):63-8. PubMed ID: 25679113 [TBL] [Abstract][Full Text] [Related]
9. IL-17A and IFN-γ synergistically induce RNase 7 expression via STAT3 in primary keratinocytes. Simanski M; Rademacher F; Schröder L; Schumacher HM; Gläser R; Harder J PLoS One; 2013; 8(3):e59531. PubMed ID: 23555696 [TBL] [Abstract][Full Text] [Related]
11. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. Nomura I; Goleva E; Howell MD; Hamid QA; Ong PY; Hall CF; Darst MA; Gao B; Boguniewicz M; Travers JB; Leung DY J Immunol; 2003 Sep; 171(6):3262-9. PubMed ID: 12960356 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-125a Correlates with Decreased Psoriasis Severity and Inflammation and Represses Keratinocyte Proliferation. Su F; Jin L; Liu W Dermatology; 2021; 237(4):568-578. PubMed ID: 33735868 [TBL] [Abstract][Full Text] [Related]
14. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Hölttä V; Klemetti P; Sipponen T; Westerholm-Ormio M; Kociubinski G; Salo H; Räsänen L; Kolho KL; Färkkilä M; Savilahti E; Vaarala O Inflamm Bowel Dis; 2008 Sep; 14(9):1175-84. PubMed ID: 18512248 [TBL] [Abstract][Full Text] [Related]
15. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients. Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497 [TBL] [Abstract][Full Text] [Related]
16. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis. Kolbinger F; Loesche C; Valentin MA; Jiang X; Cheng Y; Jarvis P; Peters T; Calonder C; Bruin G; Polus F; Aigner B; Lee DM; Bodenlenz M; Sinner F; Pieber TR; Patel DD J Allergy Clin Immunol; 2017 Mar; 139(3):923-932.e8. PubMed ID: 27502297 [TBL] [Abstract][Full Text] [Related]
17. The synergistic activities of the combination of tumour necrosis factor-α, interleukin-17A and interferon-γ in epidermal keratinocytes. Morizane S; Nomura H; Tachibana K; Nakagawa Y; Iwatsuki K Br J Dermatol; 2018 Aug; 179(2):496-498. PubMed ID: 29432653 [No Abstract] [Full Text] [Related]
18. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. Zaba LC; Suárez-Fariñas M; Fuentes-Duculan J; Nograles KE; Guttman-Yassky E; Cardinale I; Lowes MA; Krueger JG J Allergy Clin Immunol; 2009 Nov; 124(5):1022-10.e1-395. PubMed ID: 19895991 [TBL] [Abstract][Full Text] [Related]
19. Psoriasis Targeted Therapy: Characterization of Interleukin 17A Expression in Subtypes of Psoriasis. Lee E; Zarei M; LaSenna C; Villada G; Romanelli P J Drugs Dermatol; 2015 Oct; 14(10):1133-6. PubMed ID: 26461825 [TBL] [Abstract][Full Text] [Related]
20. [The effects of recombinant human beta-defensin-3 on expression of interleukin-17A and interleukin-22 in BEAS-2B cell]. Guo BY; Xie GC; Duan ZJ; Xia LJ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):260-2. PubMed ID: 24579469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]